Pull to refresh
Logo
Dana-Farber breaks ground on dedicated cancer hospital in Boston

Dana-Farber breaks ground on dedicated cancer hospital in Boston

Built World

The 300-bed Lavine Bekenstein Cancer Hospital anchors Dana-Farber's move from Brigham to Beth Israel Deaconess

Today: Groundbreaking ceremony; breast oncology transition begins

Overview

Updated 1 hour ago

Dana-Farber Cancer Institute broke ground Monday on a 300-bed hospital built solely for cancer patients, the first such inpatient facility in the Boston region. The Lavine Bekenstein Cancer Hospital, set to open in 2031, sits on the former Joslin Diabetes Center site on Brookline Avenue.

The hospital anchors Dana-Farber's decision to leave its decades-long partnership with Brigham and Women's Hospital and align with Beth Israel Lahey Health. It ends Dana-Farber's reliance on a general hospital for inpatient beds and reorders competition in Boston's hospital market.

Why it matters

Dana-Farber's move from Brigham to Beth Israel Deaconess reorders Boston's hospital hierarchy and gives the region its first hospital built solely for cancer patients.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

300
Inpatient beds
Across ten floors, including 30 ICU beds and a 16-bed observation suite.
$1.68B
Estimated project cost
Funded by the largest single gift in Dana-Farber history.
2,400
Workers to be hired
Dana-Farber plans to hire over four years, including 600 nurses.
450,000
Square feet
Total size of the hospital building.

Voices

Curated perspectives — historical figures and your fellow readers.

Ever wondered what historical figures would say about today's headlines?

Sign up to generate historical perspectives on this story.

People Involved

Organizations Involved

Timeline

2023 2031

7 events Latest: Today
Tap a bar to jump to that date
  1. Hospital opens to first patients

    Upcoming Opening

    The Lavine Bekenstein Cancer Hospital admits its first inpatient.

  2. Construction complete

    Upcoming Construction

    Interior finishing work concludes and the building is ready for occupancy.

  3. Dana-Farber and Mass General Brigham formally separate

    Upcoming Transition

    The two institutions end their partnership. Dana-Farber houses hospitalized cancer patients at Beth Israel Deaconess in the interim.

  4. Groundbreaking ceremony; breast oncology transition begins

    Today Milestone

    Dana-Farber breaks ground on the Lavine Bekenstein Cancer Hospital. The same day, breast oncology services begin moving from Brigham to Beth Israel Deaconess.

  5. Construction begins with Joslin demolition

    Construction

    Demolition of the former Joslin Diabetes Center begins at One Joslin Place, preparing the site for the new hospital.

  6. Mittendorf joins Beth Israel Deaconess

    Hiring

    Breast surgeon Elizabeth Mittendorf, formerly at Brigham, joins BIDMC to lead its new breast surgery division.

  7. Dana-Farber announces move to Beth Israel Lahey

    Decision

    Dana-Farber says it will leave its decades-long partnership with Brigham and Women's Hospital and align with Beth Israel Lahey Health.

Scenarios

1

Lavine Bekenstein Cancer Hospital opens on schedule in 2031

Likely Resolves by End of 2031

Discussed by: Dana-Farber and Beth Israel Deaconess officials

Construction follows the published schedule: foundation work through 2029, interior finishing through fall 2030, and first patients in 2031. Dana-Farber moves its hospitalized cancer patients from Beth Israel Deaconess into the new building in stages.

2

Construction delays push hospital opening past 2031

Possible Resolves by End of 2031

Discussed by: Boston Business Journal, construction industry observers

Delays in the complex demolition and construction work, or in the phased transition from Brigham to Beth Israel, push the opening into 2032 or later. Dana-Farber continues housing hospitalized patients at Beth Israel Deaconess in the interim.

3

Brigham-to-Beth Israel transition disrupts patient care

Possible Resolves by End of 2028

Discussed by: Boston Globe

The phased move of treatment centers from Brigham to Beth Israel Deaconess, which began with breast oncology in October 2026, encounters operational problems. Patient confusion, staffing gaps, or coordination failures between the two institutions could disrupt care during the multi-year transition.

Historical Context

2 moments from history that rhyme with this story — and how they unfolded.

1884

Memorial Sloan Kettering Cancer Center (1884)

Founded as the New York Cancer Hospital, it was one of the first hospitals in the United States dedicated exclusively to cancer care. It later became Memorial Sloan Kettering, now one of the world's leading cancer centers.

Then

The hospital established the model of a standalone facility focused solely on cancer treatment and research.

Now

Memorial Sloan Kettering grew into a global leader in cancer care, showing that dedicated cancer hospitals can concentrate expertise and resources.

Why this matters now

Dana-Farber's new hospital follows the same model: a facility built specifically for cancer patients, rather than shared beds in a general hospital.

1941

MD Anderson Cancer Center (1941)

The Texas legislature established MD Anderson as a dedicated cancer hospital. It grew into one of the largest and most respected cancer centers in the world.

Then

Texas created a state-funded institution focused entirely on cancer research and treatment.

Now

MD Anderson became a model for how dedicated cancer centers can drive research and attract specialized talent.

Why this matters now

Like MD Anderson, Dana-Farber is building a dedicated inpatient facility to concentrate cancer expertise, rather than relying on a general hospital partner.

Sources

(8)